0.000USD0.000åå ŽååŒÂ 07/24, 09:30 (ET)
222.71MæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
äž»èŠããŒã¿
5.280å§å€
5.410é«å€
1.63Kåºæ¥é«
æå€±é¡çŽè¿12ã¶æPER
æå€±é¡äºæ³PER
--çŽè¿12ã¶æé
åœ
0.00%売買å転ç
5.370忥çµå€
5.225å®å€
7.62K売買代é
æå€±é¡æ ªäŸ¡åçç
0.81PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
-15.12%ç·è³ç£å©çç
26.38052é±é«å€
-0.01åºæ¥é«æ¯ç%
-27.45MçŽå©ç
41.24Mæ ªåŒæ°
-1.13571æ ªåœããå©çïŒEPSïŒ
1.21ããŒã¿å€
-17.06%èªå·±è³æ¬å©çç
5.90052é±å®å€
3.45%æ¯ãå¹
76.06%ç²å©çç
222.71MæäŸ¡ç·é¡
0.29ãªã¹ã¯ãªã¿ãŒã³
3.86%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-23 äž»èŠã€ã³ãµã€ã
Rxsight Incã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçå¥å
šã§ããæé·ã®å¯èœæ§ã¯é¡èã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»çæ©åš & å忥çã§ã®é äœã¯200äž69äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããããŒã«ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯8.57ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžéãã¬ã³ããšäºæ³ãããŸããéå»1ãæã®æ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯å¹³åçã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Rxsight Incã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Rxsight Incã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
Rxsight Inc ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
Zimmer Biomet Holdings Inc
ZBH
31
ææšî
ææš
売ã(1)
äžç«(5)
è²·ã(1)
ç§»åå¹³å
売ã(3)
äžç«(0)
è²·ã(3)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Rxsight Incã®äŒæ¥æ
å ±î
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
äŒæ¥ã³ãŒãRXST
äŒæ¥åRxsight Inc
æé«çµå¶è²¬ä»»è
ãCEOãKurtz (Ron M)
ãŠã§ããµã€ãhttps://www.rxsight.com/
æ ªäž»çµ±èšî
ãããã質å
Rxsight IncïŒRXSTïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îRxsight IncïŒRXSTïŒã®çŸåšã®æ ªäŸ¡ã¯5.39ã§ãã
Rxsight Incã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îRxsight Incã®ãã£ãã«ãŒã·ã³ãã«ã¯RXSTã§ãã
Rxsight Incã®52é±é«å€ã¯ãããã§ããïŒ
îRxsight Incã®52é±é«å€ã¯26.38ã§ãã
Rxsight Incã®52é±å®å€ã¯ãããã§ããïŒ
îRxsight Incã®52é±å®å€ã¯5.90ã§ãã
Rxsight Incã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îRxsight Incã®æäŸ¡ç·é¡ã¯222.29Mã§ãã
Rxsight Inc (RXST) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãRxsight IncïŒRXSTïŒã®ç·åè©äŸ¡ã¯signal_holdã§ãç®æšæ ªäŸ¡ã¯8.57ã§ãã
Rxsight Inc (RXST) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îRxsight IncïŒRXSTïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-0.95ã§ãã